NHNKY
Price
$13.18
Change
+$0.05 (+0.38%)
Updated
Jun 5 closing price
Capitalization
2.23B
TRUMY
Price
$17.95
Change
-$0.19 (-1.05%)
Updated
Jun 5 closing price
Capitalization
24.6B
62 days until earnings call
Interact to see
Advertisement

NHNKY vs TRUMY

Header iconNHNKY vs TRUMY Comparison
Open Charts NHNKY vs TRUMYBanner chart's image
Nihon Kohden
Price$13.18
Change+$0.05 (+0.38%)
Volume$1.28K
Capitalization2.23B
Terumo
Price$17.95
Change-$0.19 (-1.05%)
Volume$122.65K
Capitalization24.6B
NHNKY vs TRUMY Comparison Chart
Loading...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NHNKY vs. TRUMY commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NHNKY is a StrongBuy and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (NHNKY: $13.18 vs. TRUMY: $17.95)
Brand notoriety: NHNKY and TRUMY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NHNKY: 15% vs. TRUMY: 72%
Market capitalization -- NHNKY: $2.23B vs. TRUMY: $24.6B
NHNKY [@Medical Specialties] is valued at $2.23B. TRUMY’s [@Medical Specialties] market capitalization is $24.6B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NHNKY’s FA Score shows that 2 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • NHNKY’s FA Score: 2 green, 3 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, NHNKY is a better buy in the long-term than TRUMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NHNKY’s TA Score shows that 6 TA indicator(s) are bullish while TRUMY’s TA Score has 3 bullish TA indicator(s).

  • NHNKY’s TA Score: 6 bullish, 2 bearish.
  • TRUMY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NHNKY is a better buy in the short-term than TRUMY.

Price Growth

NHNKY (@Medical Specialties) experienced а +9.70% price change this week, while TRUMY (@Medical Specialties) price change was -4.37% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.10%. For the same industry, the average monthly price growth was +5.39%, and the average quarterly price growth was +1.86%.

Reported Earning Dates

NHNKY is expected to report earnings on May 13, 2025.

TRUMY is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+2.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRUMY($24.6B) has a higher market cap than NHNKY($2.23B). TRUMY has higher P/E ratio than NHNKY: TRUMY (38.46) vs NHNKY (18.12). TRUMY (-7.949) and NHNKY (-8.153) have similar YTD gains . TRUMY has higher annual earnings (EBITDA): 185B vs. NHNKY (27.2B). TRUMY has more cash in the bank: 163B vs. NHNKY (43.7B). NHNKY has less debt than TRUMY: NHNKY (433M) vs TRUMY (232B). TRUMY has higher revenues than NHNKY: TRUMY (798B) vs NHNKY (202B).
NHNKYTRUMYNHNKY / TRUMY
Capitalization2.23B24.6B9%
EBITDA27.2B185B15%
Gain YTD-8.153-7.949103%
P/E Ratio18.1238.4647%
Revenue202B798B25%
Total Cash43.7B163B27%
Total Debt433M232B0%
FUNDAMENTALS RATINGS
NHNKY vs TRUMY: Fundamental Ratings
NHNKY
TRUMY
OUTLOOK RATING
1..100
7060
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
10082
SMR RATING
1..100
10100
PRICE GROWTH RATING
1..100
6261
P/E GROWTH RATING
1..100
6168
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NHNKY's Valuation (16) in the null industry is somewhat better than the same rating for TRUMY (61). This means that NHNKY’s stock grew somewhat faster than TRUMY’s over the last 12 months.

TRUMY's Profit vs Risk Rating (82) in the null industry is in the same range as NHNKY (100). This means that TRUMY’s stock grew similarly to NHNKY’s over the last 12 months.

NHNKY's SMR Rating (10) in the null industry is significantly better than the same rating for TRUMY (100). This means that NHNKY’s stock grew significantly faster than TRUMY’s over the last 12 months.

TRUMY's Price Growth Rating (61) in the null industry is in the same range as NHNKY (62). This means that TRUMY’s stock grew similarly to NHNKY’s over the last 12 months.

NHNKY's P/E Growth Rating (61) in the null industry is in the same range as TRUMY (68). This means that NHNKY’s stock grew similarly to TRUMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NHNKYTRUMY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
64%
Bearish Trend 25 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPAC42.850.13
+0.30%
Enerpac Tool Group Corp
NTGR30.16-0.10
-0.33%
NETGEAR
JPM261.95-2.27
-0.86%
JPMorgan Chase & Co
DLB74.46-0.78
-1.04%
Dolby Laboratories IncClass A
LFVN12.38-0.32
-2.52%
Lifevantage Corp

NHNKY and

Correlation & Price change

A.I.dvisor tells us that NHNKY and CNMD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NHNKY and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NHNKY
1D Price
Change %
NHNKY100%
+0.41%
CNMD - NHNKY
29%
Poorly correlated
+0.09%
BAX - NHNKY
26%
Poorly correlated
+0.60%
PSNL - NHNKY
25%
Poorly correlated
-1.75%
TRUMY - NHNKY
25%
Poorly correlated
-1.05%
LMAT - NHNKY
24%
Poorly correlated
+1.22%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-1.05%
HOCPY - TRUMY
51%
Loosely correlated
-1.38%
SSMXY - TRUMY
45%
Loosely correlated
-0.73%
SMTI - TRUMY
43%
Loosely correlated
-1.16%
OLYMY - TRUMY
40%
Loosely correlated
+0.23%
AZTA - TRUMY
39%
Loosely correlated
-1.15%
More